Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ischemic Heart Disease

Free Subscription Articles published in Lancet Retrieve available abstracts of 94 articles: HTML format

Single Articles

June 2009
1. GURM HS , Eagle K
   Rivaroxaban in acute coronary syndromes: too soon to know?
   Lancet. 2009.
   PubMed     Related articles   
   
   
   
2. MEGA J , Braunwald E, Mohanavelu S, Burton P, et al
   Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.
   Lancet. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. HENRY RR , Lincoff AM, Mudaliar S, Rabbia M, et al
   Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.
   Lancet. 2009.
   PubMed     Related articles    Abstract available
   
   
   
4. HOME PD , Pocock SJ, Beck-Nielsen H, Curtis PS, et al
   Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.
   Lancet. 2009.
   PubMed     Related articles    Abstract available
   
   
   May 2009
5. SHIL AB , Strohm MP
   Prasugrel STEMI subgroup analysis.
   Lancet. 2009;373:1846.
   PubMed     Related articles   
   
   
   
6. WEBSTER MW , Gladding P
   Prasugrel STEMI subgroup analysis.
   Lancet. 2009;373:1846.
   PubMed     Related articles   
   
   
   
7. FLOYD J , Wolfe S
   Prasugrel STEMI subgroup analysis.
   Lancet. 2009;373:1845-6.
   PubMed     Related articles   
   
   
   
8. MAZZONE T
   Hyperglycaemia and coronary heart disease: the meta picture.
   Lancet. 2009;373:1737-8.
   PubMed     Related articles   
   
   
   
9. RAY KK , Seshasai SR, Wijesuriya S, Sivakumaran R, et al
   Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
   Lancet. 2009;373:1765-72.
   PubMed     Related articles    Abstract available
   
   
   
10. FALCINI F , Vitale A, La Torre F, Conti G, et al
    Refractory pneumonia and high fever.
    Lancet. 2009;373:1818.
    PubMed     Related articles   
    
    
    
11. WHITE SA , Shaw JA, Sutherland DE
    Pancreas transplantation.
    Lancet. 2009;373:1808-17.
    PubMed     Related articles    Abstract available
    
    
    April 2009
12. ENRIQUEZ-SARANO M , Akins CW, Vahanian A
    Mitral regurgitation.
    Lancet. 2009;373:1382-94.
    PubMed     Related articles    Abstract available
    
    
    
13. VANDENBROUCKE JP
    The HRT controversy: observational studies and RCTs fall in line.
    Lancet. 2009;373:1233-5.
    PubMed     Related articles   
    
    
    
14. RAMARAJ R
    Cytochrome P450 2C19 polymorphism and clopidogrel after MI.
    Lancet. 2009;373:1172.
    PubMed     Related articles   
    
    
    
15. BHATTACHARYYA S , Rakhit R
    Cytochrome P450 2C19 polymorphism and clopidogrel after MI.
    Lancet. 2009;373:1171.
    PubMed     Related articles   
    
    
    
16. MIAO J , Liu R, Li Z
    Cytochrome P450 2C19 polymorphism and clopidogrel after MI.
    Lancet. 2009;373:1171-2.
    PubMed     Related articles   
    
    
    
17. BECKER G , Blum HE
    Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Lancet. 2009;373:1198-206.
    PubMed     Related articles    Abstract available
    
    
    March 2009
18. 
    Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.
    Lancet. 2009.
    PubMed     Related articles    Abstract available
    
    
    
19. WHITLOCK G , Lewington S, Sherliker P, Clarke R, et al
    Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.
    Lancet. 2009;373:1083-96.
    PubMed     Related articles    Abstract available
    
    
    
20. RIDKER PM , Danielson E, Fonseca FA, Genest J, et al
    Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
    Lancet. 2009.
    PubMed     Related articles    Abstract available
    
    
    
21. HLATKY MA , Boothroyd DB, Bravata DM, Boersma E, et al
    Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.
    Lancet. 2009.
    PubMed     Related articles    Abstract available
    
    
    
22. TAGGART DP
    PCI or CABG in coronary artery disease?
    Lancet. 2009.
    PubMed     Related articles   
    
    
    
23. KOTSEVA K , Wood D, De Backer G, De Bacquer D, et al
    Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Lancet. 2009;373:929-40.
    PubMed     Related articles    Abstract available
    
    
    
24. BECKER RC , Moliterno DJ, Jennings LK, Pieper KS, et al
    Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.
    Lancet. 2009;373:919-28.
    PubMed     Related articles    Abstract available
    
    
    
25. TRIKALINOS TA , Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, et al
    Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.
    Lancet. 2009;373:911-8.
    PubMed     Related articles    Abstract available
    
    
    
26. SERRUYS PW , Ormiston JA, Onuma Y, Regar E, et al
    A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.
    Lancet. 2009;373:897-910.
    PubMed     Related articles    Abstract available
    
    
    
27. SHERIDAN DJ , Heusch G
    Threats to the future of cardiovascular research.
    Lancet. 2009;373:875-6.
    PubMed     Related articles   
    
    
    
28. BREKKE M , Gjelsvik B
    Secondary cardiovascular risk prevention--we can do better.
    Lancet. 2009;373:873-5.
    PubMed     Related articles   
    
    
    
29. MUKHERJEE D , Moliterno DJ
    Effectiveness of PCI for non-acute coronary artery disease.
    Lancet. 2009;373:870-2.
    PubMed     Related articles   
    
    
    
30. COLOMBO A , Merlini P
    The ischaemia/bleeding balance in PCI.
    Lancet. 2009;373:872-3.
    PubMed     Related articles   
    
    
    
31. COLOMBO A , Sharp AS
    The bioabsorbable stent as a virtual prosthesis.
    Lancet. 2009;373:869-70.
    PubMed     Related articles   
    
    
    
32. HUSSEINI A , Abu-Rmeileh NM, Mikki N, Ramahi TM, et al
    Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory.
    Lancet. 2009.
    PubMed     Related articles    Abstract available
    
    
    February 2009
33. MONTALESCOT G , Wiviott SD, Braunwald E, Murphy SA, et al
    Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.
    Lancet. 2009;373:723-31.
    PubMed     Related articles    Abstract available
    
    
    
34. STONE GW
    Ischaemia versus bleeding: the art of clinical decision-making.
    Lancet. 2009;373:695-6.
    PubMed     Related articles   
    
    
    
35. HEERSPINK HJ , Ninomiya T, Zoungas S, de Zeeuw D, et al
    Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials.
    Lancet. 2009.
    PubMed     Related articles    Abstract available
    
    
    
36. ROSENSON RS , Hislop C, McConnell D, Elliott M, et al
    Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial.
    Lancet. 2009;373:649-58.
    PubMed     Related articles    Abstract available
    
    
    
37. SUTTNER S , Mayer J, Boldt J
    Perioperative beta blockade: the debate continues.
    Lancet. 2009;373:628.
    PubMed     Related articles   
    
    
    
38. CORSON MA
    Phospholipase A2 inhibitors in atherosclerosis: the race is on.
    Lancet. 2009;373:608-10.
    PubMed     Related articles   
    
    
    
39. HALL A , Strauss MH
    Telmisartan in high-risk patients intolerant of ACE inhibitors.
    Lancet. 2009;373:458.
    PubMed     Related articles   
    
    
    December 2008
40. COLLET JP , Hulot JS, Pena A, Villard E, et al
    Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.
    Lancet. 2008.
    PubMed     Related articles    Abstract available
    
    
    
41. STOREY RF
    Clopidogrel in acute coronary syndrome: to genotype or not?
    Lancet. 2008.
    PubMed     Related articles   
    
    
    
42. BRADLEY TD , Floras JS
    Obstructive sleep apnoea and its cardiovascular consequences.
    Lancet. 2008.
    PubMed     Related articles    Abstract available
    
    
    November 2008
43. HOGLUND P , Nilsson LA, Rehnqvist N
    CPR with assisted extracorporeal life support.
    Lancet. 2008;372:1878-9.
    PubMed     Related articles   
    
    
    
44. BOERSMA E , Poldermans D
    beta blockers in non-cardiac surgery: haemodynamic data needed.
    Lancet. 2008.
    PubMed     Related articles   
    
    
    
45. KIVIMAKI M , Shipley MJ, Ferrie JE, Singh-Manoux A, et al
    Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study.
    Lancet. 2008;372:1648-54.
    PubMed     Related articles    Abstract available
    
    
    
46. TOBIAS M , Rodgers A
    Can we eliminate inequalities in coronary disease? Absolutely.
    Lancet. 2008;372:1612-3.
    PubMed     Related articles   
    
    
    October 2008
47. BARON JA , Sandler RS, Bresalier RS, Lanas A, et al
    Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.
    Lancet. 2008.
    PubMed     Related articles    Abstract available
    
    
    
48. NASH DT , Nash SD
    Ranolazine for chronic stable angina.
    Lancet. 2008;372:1335-41.
    PubMed     Related articles    Abstract available
    
    
    September 2008
49. BANGALORE S , Gluud C, Wetterslev J, Messerli FH, et al
    Perioperative beta blockade.
    Lancet. 2008;372:1147-8.
    PubMed     Related articles   
    
    
    
50. YUDKIN JS
    Hyperglycaemia as a cardiovascular risk factor in diabetes.
    Lancet. 2008;372:1036-7.
    PubMed     Related articles   
    
    
    
51. OH J , Hong N, Kang SM
    Thrombus aspiration during percutaneous coronary intervention.
    Lancet. 2008;372:1034.
    PubMed     Related articles   
    
    
    
52. BONELLO L , De Labriolle A, Steinberg D, Waksman R, et al
    Thrombus aspiration during percutaneous coronary intervention.
    Lancet. 2008;372:1034.
    PubMed     Related articles   
    
    
    
53. VLAAR PJ , Svilaas T, Zijlstra F
    Thrombus aspiration during percutaneous coronary intervention - Authors' reply.
    Lancet. 2008;372:1034-1035.
    PubMed     Related articles   
    
    
    
54. EDWARDS R , Bate A, Lindquist M
    Abacavir and increased risk of myocardial infarction.
    Lancet. 2008;372:805.
    PubMed     Related articles   
    
    
    
55. SABIN CA , Worm S, Phillips AN, Lundgren JD, et al
    Abacavir and increased risk of myocardial infarction - Authors' reply.
    Lancet. 2008;372:804-805.
    PubMed     Related articles   
    
    
    
56. GOICOECHEA M , McCutchan A
    Abacavir and increased risk of myocardial infarction.
    Lancet. 2008;372:803-4.
    PubMed     Related articles   
    
    
    
57. POST FA , Campbell LJ
    Abacavir and increased risk of myocardial infarction.
    Lancet. 2008;372:803.
    PubMed     Related articles   
    
    
    
58. REIL JC , Bohm M
    BEAUTIFUL results--the slower, the better?
    Lancet. 2008;372:779-80.
    PubMed     Related articles   
    
    
    August 2008
59. WAKSMAN R
    Drug-eluting stents: is new necessarily better?
    Lancet. 2008.
    PubMed     Related articles   
    
    
    
60. WINDECKER S , Serruys PW, Wandel S, Buszman P, et al
    Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.
    Lancet. 2008.
    PubMed     Related articles    Abstract available
    
    
    
61. BHATTI P , Sigurdson AJ, Mabuchi K
    Can low-dose radiation increase risk of cardiovascular disease?
    Lancet. 2008;372:697-9.
    PubMed     Related articles   
    
    
    
62. FOX K , Ford I, Steg PG, Tendera M, et al
    Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
    Lancet. 2008.
    PubMed     Related articles    Abstract available
    
    
    
63. FOX K , Ford I, Steg PG, Tendera M, et al
    Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2008.
    PubMed     Related articles    Abstract available
    
    
    
64. 
    Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
    Lancet. 2008.
    PubMed     Related articles    Abstract available
    
    
    
65. WHITE HD , Chew DP
    Acute myocardial infarction.
    Lancet. 2008;372:570-84.
    PubMed     Related articles    Abstract available
    
    
    
66. VAN'T HOF AW , Ten Berg J, Heestermans T, Dill T, et al
    Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2008;372:537-46.
    PubMed     Related articles    Abstract available
    
    
    
67. FERRANTE G , Montone RA, Niccoli G
    Carotid bruits and cardiovascular death or myocardial infarction.
    Lancet. 2008;372:534.
    PubMed     Related articles   
    
    
    
68. JACKSON JL , Pickett CA, Hemann BA, Atwood JE, et al
    Carotid bruits and cardiovascular death or myocardial infarction - Authors' reply.
    Lancet. 2008;372:534-535.
    PubMed     Related articles   
    
    
    
69. EIKELBOOM JW , Guyatt G, Hirsh J
    Guidelines for anticoagulant use in acute coronary syndromes - Authors' reply.
    Lancet. 2008;372:533-534.
    PubMed     Related articles   
    
    
    
70. BASSAND JP , Hamm C
    Guidelines for anticoagulant use in acute coronary syndromes.
    Lancet. 2008;372:532-3.
    PubMed     Related articles   
    
    
    
71. GUIJARRO C
    In search of lost time: age, CVD, and intensive statin treatment.
    Lancet. 2008;372:535.
    PubMed     Related articles   
    
    
    
72. RAMARAJ R
    Intensive antiplatelet therapy for reduction of ischaemic events.
    Lancet. 2008;372:531.
    PubMed     Related articles   
    
    
    
73. MONTALESCOT G
    Mechanical reperfusion: treat well, treat on time too.
    Lancet. 2008;372:509-10.
    PubMed     Related articles   
    
    
    July 2008
74. MCQUEEN MJ , Hawken S, Wang X, Ounpuu S, et al
    Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.
    Lancet. 2008;372:224-33.
    PubMed     Related articles    Abstract available
    
    
    
75. LIND L
    Apolipoprotein B/A1 and risk of cardiovascular disease.
    Lancet. 2008;372:185-6.
    PubMed     Related articles   
    
    
    June 2008
76. BAVRY AA , Bhatt DL
    Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.
    Lancet. 2008;371:2134-43.
    PubMed     Related articles    Abstract available
    
    
    
77. WOOD DA , Kotseva K, Connolly S, Jennings C, et al
    Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controll
    Lancet. 2008;371:1999-2012.
    PubMed     Related articles    Abstract available
    
    
    
78. OWEN A
    CARESS-in-AMI study.
    Lancet. 2008;371:1997-8.
    PubMed     Related articles   
    
    
    
79. VLAAR PJ , Svilaas T, van der Horst IC, Diercks GF, et al
    Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.
    Lancet. 2008;371:1915-20.
    PubMed     Related articles    Abstract available
    
    
    
80. BURZOTTA F , Crea F
    Thrombus-aspiration: a victory in the war against no reflow.
    Lancet. 2008;371:1889-90.
    PubMed     Related articles   
    
    
    May 2008
81. FLEISHER LA , Poldermans D
    Perioperative beta blockade: where do we go from here?
    Lancet. 2008;371:1813-4.
    PubMed     Related articles   
    
    
    
82. MAZZONE T , Chait A, Plutzky J
    Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.
    Lancet. 2008;371:1800-9.
    PubMed     Related articles    Abstract available
    
    
    
83. TARDIF JC , McMurray JJ, Klug E, Small R, et al
    Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2008;371:1761-8.
    PubMed     Related articles    Abstract available
    
    
    
84. LINDSTROM J , Uusitupa M
    Lifestyle intervention, diabetes, and cardiovascular disease.
    Lancet. 2008;371:1731-3.
    PubMed     Related articles   
    
    
    
85. DUFFY SJ , Dart AM
    Novel cardiac therapies and innocent by standers.
    Lancet. 2008;371:1726-8.
    PubMed     Related articles   
    
    
    
86. SATTAR N , McConnachie A, Shaper AG, Blauw GJ, et al
    Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.
    Lancet. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
87. PICKETT CA , Jackson JL, Hemann BA, Atwood JE, et al
    Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis.
    Lancet. 2008;371:1587-94.
    PubMed     Related articles    Abstract available
    
    
    
88. EIKELBOOM J , Guyatt G, Hirsh J
    Guidelines for anticoagulant use in acute coronary syndromes.
    Lancet. 2008;371:1559-61.
    PubMed     Related articles   
    
    
    
89. ABOYANS V , Lacroix P
    Carotid bruit: good for silent cardiovascular disease?
    Lancet. 2008;371:1554-6.
    PubMed     Related articles   
    
    
    April 2008
90. XAVIER D , Pais P, Devereaux PJ, Xie C, et al
    Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data.
    Lancet. 2008;371:1435-42.
    PubMed     Related articles    Abstract available
    
    
    
91. EAGLE K
    Coronary artery disease in India: challenges and opportunities.
    Lancet. 2008;371:1394-5.
    PubMed     Related articles   
    
    
    
92. AJANI AE , Lefkovits J
    Approaching an age of reason with antiplatelet therapy.
    Lancet. 2008;371:1315-6.
    PubMed     Related articles   
    
    
    
93. ANTOINE-JONVILLE S , Hue O
    Cholesterol, statins, and mortality.
    Lancet. 2008;371:1163.
    PubMed     Related articles   
    
    
    
94. LAW M , Wald N
    Cholesterol, statins, and mortality.
    Lancet. 2008;371:1161-2.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: